Analytical & Quality
The Analytical & Quality track at BPI 2018 is designed to help ensure your products meet today’s increasing analytical and quality regulations. Industry leaders share novel insights and strategies including emerging analytical tools that deliver more information with greater speed for analytical method lifecycle development, as well as numerous analytical case studies that you can apply to your own projects.
Sanchayita Ghose, PhD, Director, Biologics Process Development, Bristol-Myers Squibb
Full Presentation: 10:30 am, Thurs. Sep. 6, 2018
Sanchayita Ghose talks about Bristol-Myers Squibbs’ next-generation facility in Devens, Massachusetts, set to be operational in the second quarter of next year. The firm is adopting a hybrid approach at the facility, incorporating elements of continuous bioprocessing.
Chris Chumsae, Senior Scientist, Protein Analytics, AbbVie BioResearch Center
Full Presentation: 10:15 am, Weds. Sep. 5, 2018
Chris Chumsae describes analytics as “detective work” and gives an overview of how cutting edge analytical techniques can revolutionize the drug development process, from clone selection all the way to cell protein proteomics.
Balaji Viswanathan, Principal Scientist, Method Validation and Analytical Technology Transfer (VATT) Group, Pfizer BioTherapeutics
Full Presentation: 7:55 am, Weds. Sep. 5, 2018
Balaji Viswanathan talks to us about the most pressing area industry is currently facing surrounds compliance, and how maintaining compliance is a key factor in the whole lifecycle.